These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32194542)

  • 21. VEGF as a modulator of the innate immune response in glioblastoma.
    Turkowski K; Brandenburg S; Mueller A; Kremenetskaia I; Bungert AD; Blank A; Felsenstein M; Vajkoczy P
    Glia; 2018 Jan; 66(1):161-174. PubMed ID: 28948650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTY720 attenuates excitotoxicity and neuroinflammation.
    Cipriani R; Chara JC; Rodríguez-Antigüedad A; Matute C
    J Neuroinflammation; 2015 May; 12():86. PubMed ID: 25953296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.
    Jacobs VL; Landry RP; Liu Y; Romero-Sandoval EA; De Leo JA
    Neuro Oncol; 2012 Feb; 14(2):119-31. PubMed ID: 22086978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway.
    Beider K; Rosenberg E; Bitner H; Shimoni A; Leiba M; Koren-Michowitz M; Ribakovsky E; Klein S; Olam D; Weiss L; Wald H; Abraham M; Galun E; Peled A; Nagler A
    Clin Cancer Res; 2017 Apr; 23(7):1733-1747. PubMed ID: 27697999
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-PD-1 Induces M1 Polarization in the Glioma Microenvironment and Exerts Therapeutic Efficacy in the Absence of CD8 Cytotoxic T Cells.
    Rao G; Latha K; Ott M; Sabbagh A; Marisetty A; Ling X; Zamler D; Doucette TA; Yang Y; Kong LY; Wei J; Fuller GN; Benavides F; Sonabend AM; Long J; Li S; Curran M; Heimberger AB
    Clin Cancer Res; 2020 Sep; 26(17):4699-4712. PubMed ID: 32554515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of luteolin on glioblastoma's immune microenvironment and tumor growth suppression.
    Zong S; Li X; Zhang G; Hu J; Li H; Guo Z; Zhao X; Chen J; Wang Y; Jing Z
    Phytomedicine; 2024 Jul; 130():155611. PubMed ID: 38776737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide.
    Zhang L; Wang H
    Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.
    Gravina GL; Mancini A; Colapietro A; Vitale F; Vetuschi A; Pompili S; Rossi G; Marampon F; Richardson PJ; Patient L; Patient L; Burbidge S; Festuccia C
    Tumour Biol; 2017 Jun; 39(6):1010428317695528. PubMed ID: 28639900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crosstalk between microglia and patient-derived glioblastoma cells inhibit invasion in a three-dimensional gelatin hydrogel model.
    Chen JE; Lumibao J; Leary S; Sarkaria JN; Steelman AJ; Gaskins HR; Harley BAC
    J Neuroinflammation; 2020 Nov; 17(1):346. PubMed ID: 33208156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
    Wu A; Maxwell R; Xia Y; Cardarelli P; Oyasu M; Belcaid Z; Kim E; Hung A; Luksik AS; Garzon-Muvdi T; Jackson CM; Mathios D; Theodros D; Cogswell J; Brem H; Pardoll DM; Lim M
    J Neurooncol; 2019 Jun; 143(2):241-249. PubMed ID: 31025274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation.
    Chiavari M; Ciotti GMP; Canonico F; Altieri F; Lacal PM; Graziani G; Navarra P; Lisi L
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression.
    He X; Guo Y; Yu C; Zhang H; Wang S
    Front Immunol; 2023; 14():1097880. PubMed ID: 36969175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia.
    Dang W; Xiao J; Ma Q; Miao J; Cao M; Chen L; Shi Y; Yao X; Yu S; Liu X; Cui Y; Zhang X; Bian X
    Brain Tumor Pathol; 2021 Jul; 38(3):189-200. PubMed ID: 34231121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
    Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
    Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo.
    Yoo JY; Swanner J; Otani Y; Nair M; Park F; Banasavadi-Siddegowda Y; Liu J; Jaime-Ramirez AC; Hong B; Geng F; Guo D; Bystry D; Phelphs M; Quadri H; Lee TJ; Kaur B
    Neuro Oncol; 2019 Sep; 21(9):1131-1140. PubMed ID: 31063549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.